Intriguingly, there is a specific reduction in synaptophysin levels at the earliest stages of Alzheimer’s disease with no change in the levels of other presynaptic proteins such as synaptotagmin-1 or GAP-43 [34]. The gene discussed is GAP43; the disease is early-onset autosomal dominant Alzheimer disease.